Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Pharmacoepidemiol Drug Saf. 2014 Apr 30;23(6):619–627. doi: 10.1002/pds.3616

Figure 2.

Figure 2

Emulated prospective monitoring results for myocardial infarction among initiators of rofecoxib versus initiators of non-selective non-steroidal anti-inflammatory drugs

Monitoring period 1 begins May 20, 1999, when rofecoxib prescriptions first appeared in the databases. Each monitoring period is a calendar quarter in duration.